Combining Diagnostics and Artificial Intelligence enabling Precision Medicine, Risk Prediction and Prognosis to Guide Therapy.

How it works

NASH Patient

If diagnosed, you may be at an early stage or late stage of liver disease. Here is how our products helps you to examine the disease

COVID Patient

LIVERFASt™ can safely provide the complete liver assessment clinically needed, whether a COVID-19 patient has pre-existing conditions such as hepatitis B or C, NASH or Fatty Liver or even those with undiagnosed liver disease.

Learn more about integrating our products in your organization